Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Children’s Claratyne
Active Ingredient:	Loratadine 1mg/mL
Dosage Form:	Syrup
New Zealand Sponsor:	Bayer New Zealand Limited
Manufacturer:	Delpharm Montréal Inc, Quebec, Canada

*Product:*	Suxamethonium Chloride
Active Ingredient:	Suxamethonium chloride dihydrate 5%w/w
Dosage Form:	Solution for injection
New Zealand Sponsor:	Max Health Limited
Manufacturer:	Macarthys Pharmaceuticals T/A Martindale Pharma, Romford, United Kingdom

Dated this 11th day of August 2023.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule